Global Neuraminidase Inhibitors Drug Market Growth (Status and Outlook) 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
Neuraminidase Inhibitors (NAIs) are the type of drugs that are used to block the neuraminidase enzyme.
LPI (LP Information)' newest research report, the “Neuraminidase Inhibitors Drug Industry Forecast” looks at past sales and reviews total world Neuraminidase Inhibitors Drug sales in 2022, providing a comprehensive analysis by region and market sector of projected Neuraminidase Inhibitors Drug sales for 2023 through 2029. With Neuraminidase Inhibitors Drug sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Neuraminidase Inhibitors Drug industry.
This Insight Report provides a comprehensive analysis of the global Neuraminidase Inhibitors Drug landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Neuraminidase Inhibitors Drug portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Neuraminidase Inhibitors Drug market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Neuraminidase Inhibitors Drug and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Neuraminidase Inhibitors Drug.
The global Neuraminidase Inhibitors Drug market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Neuraminidase Inhibitors Drug is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Neuraminidase Inhibitors Drug is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Neuraminidase Inhibitors Drug is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Neuraminidase Inhibitors Drug players cover Roche, GSK, Gilead Sciences and Daiichi Sankyo, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Neuraminidase Inhibitors Drug market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Neuraminidase Inhibitors (NAIs) are the type of drugs that are used to block the neuraminidase enzyme.
LPI (LP Information)' newest research report, the “Neuraminidase Inhibitors Drug Industry Forecast” looks at past sales and reviews total world Neuraminidase Inhibitors Drug sales in 2022, providing a comprehensive analysis by region and market sector of projected Neuraminidase Inhibitors Drug sales for 2023 through 2029. With Neuraminidase Inhibitors Drug sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Neuraminidase Inhibitors Drug industry.
This Insight Report provides a comprehensive analysis of the global Neuraminidase Inhibitors Drug landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Neuraminidase Inhibitors Drug portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Neuraminidase Inhibitors Drug market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Neuraminidase Inhibitors Drug and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Neuraminidase Inhibitors Drug.
The global Neuraminidase Inhibitors Drug market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Neuraminidase Inhibitors Drug is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Neuraminidase Inhibitors Drug is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Neuraminidase Inhibitors Drug is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Neuraminidase Inhibitors Drug players cover Roche, GSK, Gilead Sciences and Daiichi Sankyo, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Neuraminidase Inhibitors Drug market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
- Oseltamivir
- Zanamivir
- Peramivir
- Laninamivir
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Roche
- GSK
- Gilead Sciences
- Daiichi Sankyo
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Neuraminidase Inhibitors Drug Market Size 2018-2029
2.1.2 Neuraminidase Inhibitors Drug Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Neuraminidase Inhibitors Drug Segment by Type
2.2.1 Oseltamivir
2.2.2 Zanamivir
2.2.3 Peramivir
2.2.4 Laninamivir
2.3 Neuraminidase Inhibitors Drug Market Size by Type
2.3.1 Neuraminidase Inhibitors Drug Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Neuraminidase Inhibitors Drug Market Size Market Share by Type (2018-2023)
2.4 Neuraminidase Inhibitors Drug Segment by Application
2.4.1 Hospital Pharmacy
2.4.2 Retail Pharmacy
2.4.3 Online Pharmacy
2.4.4 Others
2.5 Neuraminidase Inhibitors Drug Market Size by Application
2.5.1 Neuraminidase Inhibitors Drug Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Neuraminidase Inhibitors Drug Market Size Market Share by Application (2018-2023)
3 NEURAMINIDASE INHIBITORS DRUG MARKET SIZE BY PLAYER
3.1 Neuraminidase Inhibitors Drug Market Size Market Share by Players
3.1.1 Global Neuraminidase Inhibitors Drug Revenue by Players (2018-2023)
3.1.2 Global Neuraminidase Inhibitors Drug Revenue Market Share by Players (2018-2023)
3.2 Global Neuraminidase Inhibitors Drug Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 NEURAMINIDASE INHIBITORS DRUG BY REGIONS
4.1 Neuraminidase Inhibitors Drug Market Size by Regions (2018-2023)
4.2 Americas Neuraminidase Inhibitors Drug Market Size Growth (2018-2023)
4.3 APAC Neuraminidase Inhibitors Drug Market Size Growth (2018-2023)
4.4 Europe Neuraminidase Inhibitors Drug Market Size Growth (2018-2023)
4.5 Middle East & Africa Neuraminidase Inhibitors Drug Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas Neuraminidase Inhibitors Drug Market Size by Country (2018-2023)
5.2 Americas Neuraminidase Inhibitors Drug Market Size by Type (2018-2023)
5.3 Americas Neuraminidase Inhibitors Drug Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Neuraminidase Inhibitors Drug Market Size by Region (2018-2023)
6.2 APAC Neuraminidase Inhibitors Drug Market Size by Type (2018-2023)
6.3 APAC Neuraminidase Inhibitors Drug Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Neuraminidase Inhibitors Drug by Country (2018-2023)
7.2 Europe Neuraminidase Inhibitors Drug Market Size by Type (2018-2023)
7.3 Europe Neuraminidase Inhibitors Drug Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Neuraminidase Inhibitors Drug by Region (2018-2023)
8.2 Middle East & Africa Neuraminidase Inhibitors Drug Market Size by Type (2018-2023)
8.3 Middle East & Africa Neuraminidase Inhibitors Drug Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL NEURAMINIDASE INHIBITORS DRUG MARKET FORECAST
10.1 Global Neuraminidase Inhibitors Drug Forecast by Regions (2024-2029)
10.1.1 Global Neuraminidase Inhibitors Drug Forecast by Regions (2024-2029)
10.1.2 Americas Neuraminidase Inhibitors Drug Forecast
10.1.3 APAC Neuraminidase Inhibitors Drug Forecast
10.1.4 Europe Neuraminidase Inhibitors Drug Forecast
10.1.5 Middle East & Africa Neuraminidase Inhibitors Drug Forecast
10.2 Americas Neuraminidase Inhibitors Drug Forecast by Country (2024-2029)
10.2.1 United States Neuraminidase Inhibitors Drug Market Forecast
10.2.2 Canada Neuraminidase Inhibitors Drug Market Forecast
10.2.3 Mexico Neuraminidase Inhibitors Drug Market Forecast
10.2.4 Brazil Neuraminidase Inhibitors Drug Market Forecast
10.3 APAC Neuraminidase Inhibitors Drug Forecast by Region (2024-2029)
10.3.1 China Neuraminidase Inhibitors Drug Market Forecast
10.3.2 Japan Neuraminidase Inhibitors Drug Market Forecast
10.3.3 Korea Neuraminidase Inhibitors Drug Market Forecast
10.3.4 Southeast Asia Neuraminidase Inhibitors Drug Market Forecast
10.3.5 India Neuraminidase Inhibitors Drug Market Forecast
10.3.6 Australia Neuraminidase Inhibitors Drug Market Forecast
10.4 Europe Neuraminidase Inhibitors Drug Forecast by Country (2024-2029)
10.4.1 Germany Neuraminidase Inhibitors Drug Market Forecast
10.4.2 France Neuraminidase Inhibitors Drug Market Forecast
10.4.3 UK Neuraminidase Inhibitors Drug Market Forecast
10.4.4 Italy Neuraminidase Inhibitors Drug Market Forecast
10.4.5 Russia Neuraminidase Inhibitors Drug Market Forecast
10.5 Middle East & Africa Neuraminidase Inhibitors Drug Forecast by Region (2024-2029)
10.5.1 Egypt Neuraminidase Inhibitors Drug Market Forecast
10.5.2 South Africa Neuraminidase Inhibitors Drug Market Forecast
10.5.3 Israel Neuraminidase Inhibitors Drug Market Forecast
10.5.4 Turkey Neuraminidase Inhibitors Drug Market Forecast
10.5.5 GCC Countries Neuraminidase Inhibitors Drug Market Forecast
10.6 Global Neuraminidase Inhibitors Drug Forecast by Type (2024-2029)
10.7 Global Neuraminidase Inhibitors Drug Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 Roche
11.1.1 Roche Company Information
11.1.2 Roche Neuraminidase Inhibitors Drug Product Offered
11.1.3 Roche Neuraminidase Inhibitors Drug Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Roche Main Business Overview
11.1.5 Roche Latest Developments
11.2 GSK
11.2.1 GSK Company Information
11.2.2 GSK Neuraminidase Inhibitors Drug Product Offered
11.2.3 GSK Neuraminidase Inhibitors Drug Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 GSK Main Business Overview
11.2.5 GSK Latest Developments
11.3 Gilead Sciences
11.3.1 Gilead Sciences Company Information
11.3.2 Gilead Sciences Neuraminidase Inhibitors Drug Product Offered
11.3.3 Gilead Sciences Neuraminidase Inhibitors Drug Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Gilead Sciences Main Business Overview
11.3.5 Gilead Sciences Latest Developments
11.4 Daiichi Sankyo
11.4.1 Daiichi Sankyo Company Information
11.4.2 Daiichi Sankyo Neuraminidase Inhibitors Drug Product Offered
11.4.3 Daiichi Sankyo Neuraminidase Inhibitors Drug Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Daiichi Sankyo Main Business Overview
11.4.5 Daiichi Sankyo Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Neuraminidase Inhibitors Drug Market Size 2018-2029
2.1.2 Neuraminidase Inhibitors Drug Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Neuraminidase Inhibitors Drug Segment by Type
2.2.1 Oseltamivir
2.2.2 Zanamivir
2.2.3 Peramivir
2.2.4 Laninamivir
2.3 Neuraminidase Inhibitors Drug Market Size by Type
2.3.1 Neuraminidase Inhibitors Drug Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Neuraminidase Inhibitors Drug Market Size Market Share by Type (2018-2023)
2.4 Neuraminidase Inhibitors Drug Segment by Application
2.4.1 Hospital Pharmacy
2.4.2 Retail Pharmacy
2.4.3 Online Pharmacy
2.4.4 Others
2.5 Neuraminidase Inhibitors Drug Market Size by Application
2.5.1 Neuraminidase Inhibitors Drug Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Neuraminidase Inhibitors Drug Market Size Market Share by Application (2018-2023)
3 NEURAMINIDASE INHIBITORS DRUG MARKET SIZE BY PLAYER
3.1 Neuraminidase Inhibitors Drug Market Size Market Share by Players
3.1.1 Global Neuraminidase Inhibitors Drug Revenue by Players (2018-2023)
3.1.2 Global Neuraminidase Inhibitors Drug Revenue Market Share by Players (2018-2023)
3.2 Global Neuraminidase Inhibitors Drug Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 NEURAMINIDASE INHIBITORS DRUG BY REGIONS
4.1 Neuraminidase Inhibitors Drug Market Size by Regions (2018-2023)
4.2 Americas Neuraminidase Inhibitors Drug Market Size Growth (2018-2023)
4.3 APAC Neuraminidase Inhibitors Drug Market Size Growth (2018-2023)
4.4 Europe Neuraminidase Inhibitors Drug Market Size Growth (2018-2023)
4.5 Middle East & Africa Neuraminidase Inhibitors Drug Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas Neuraminidase Inhibitors Drug Market Size by Country (2018-2023)
5.2 Americas Neuraminidase Inhibitors Drug Market Size by Type (2018-2023)
5.3 Americas Neuraminidase Inhibitors Drug Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Neuraminidase Inhibitors Drug Market Size by Region (2018-2023)
6.2 APAC Neuraminidase Inhibitors Drug Market Size by Type (2018-2023)
6.3 APAC Neuraminidase Inhibitors Drug Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Neuraminidase Inhibitors Drug by Country (2018-2023)
7.2 Europe Neuraminidase Inhibitors Drug Market Size by Type (2018-2023)
7.3 Europe Neuraminidase Inhibitors Drug Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Neuraminidase Inhibitors Drug by Region (2018-2023)
8.2 Middle East & Africa Neuraminidase Inhibitors Drug Market Size by Type (2018-2023)
8.3 Middle East & Africa Neuraminidase Inhibitors Drug Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL NEURAMINIDASE INHIBITORS DRUG MARKET FORECAST
10.1 Global Neuraminidase Inhibitors Drug Forecast by Regions (2024-2029)
10.1.1 Global Neuraminidase Inhibitors Drug Forecast by Regions (2024-2029)
10.1.2 Americas Neuraminidase Inhibitors Drug Forecast
10.1.3 APAC Neuraminidase Inhibitors Drug Forecast
10.1.4 Europe Neuraminidase Inhibitors Drug Forecast
10.1.5 Middle East & Africa Neuraminidase Inhibitors Drug Forecast
10.2 Americas Neuraminidase Inhibitors Drug Forecast by Country (2024-2029)
10.2.1 United States Neuraminidase Inhibitors Drug Market Forecast
10.2.2 Canada Neuraminidase Inhibitors Drug Market Forecast
10.2.3 Mexico Neuraminidase Inhibitors Drug Market Forecast
10.2.4 Brazil Neuraminidase Inhibitors Drug Market Forecast
10.3 APAC Neuraminidase Inhibitors Drug Forecast by Region (2024-2029)
10.3.1 China Neuraminidase Inhibitors Drug Market Forecast
10.3.2 Japan Neuraminidase Inhibitors Drug Market Forecast
10.3.3 Korea Neuraminidase Inhibitors Drug Market Forecast
10.3.4 Southeast Asia Neuraminidase Inhibitors Drug Market Forecast
10.3.5 India Neuraminidase Inhibitors Drug Market Forecast
10.3.6 Australia Neuraminidase Inhibitors Drug Market Forecast
10.4 Europe Neuraminidase Inhibitors Drug Forecast by Country (2024-2029)
10.4.1 Germany Neuraminidase Inhibitors Drug Market Forecast
10.4.2 France Neuraminidase Inhibitors Drug Market Forecast
10.4.3 UK Neuraminidase Inhibitors Drug Market Forecast
10.4.4 Italy Neuraminidase Inhibitors Drug Market Forecast
10.4.5 Russia Neuraminidase Inhibitors Drug Market Forecast
10.5 Middle East & Africa Neuraminidase Inhibitors Drug Forecast by Region (2024-2029)
10.5.1 Egypt Neuraminidase Inhibitors Drug Market Forecast
10.5.2 South Africa Neuraminidase Inhibitors Drug Market Forecast
10.5.3 Israel Neuraminidase Inhibitors Drug Market Forecast
10.5.4 Turkey Neuraminidase Inhibitors Drug Market Forecast
10.5.5 GCC Countries Neuraminidase Inhibitors Drug Market Forecast
10.6 Global Neuraminidase Inhibitors Drug Forecast by Type (2024-2029)
10.7 Global Neuraminidase Inhibitors Drug Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 Roche
11.1.1 Roche Company Information
11.1.2 Roche Neuraminidase Inhibitors Drug Product Offered
11.1.3 Roche Neuraminidase Inhibitors Drug Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Roche Main Business Overview
11.1.5 Roche Latest Developments
11.2 GSK
11.2.1 GSK Company Information
11.2.2 GSK Neuraminidase Inhibitors Drug Product Offered
11.2.3 GSK Neuraminidase Inhibitors Drug Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 GSK Main Business Overview
11.2.5 GSK Latest Developments
11.3 Gilead Sciences
11.3.1 Gilead Sciences Company Information
11.3.2 Gilead Sciences Neuraminidase Inhibitors Drug Product Offered
11.3.3 Gilead Sciences Neuraminidase Inhibitors Drug Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Gilead Sciences Main Business Overview
11.3.5 Gilead Sciences Latest Developments
11.4 Daiichi Sankyo
11.4.1 Daiichi Sankyo Company Information
11.4.2 Daiichi Sankyo Neuraminidase Inhibitors Drug Product Offered
11.4.3 Daiichi Sankyo Neuraminidase Inhibitors Drug Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Daiichi Sankyo Main Business Overview
11.4.5 Daiichi Sankyo Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Neuraminidase Inhibitors Drug Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Oseltamivir
Table 3. Major Players of Zanamivir
Table 4. Major Players of Peramivir
Table 5. Major Players of Laninamivir
Table 6. Neuraminidase Inhibitors Drug Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 7. Global Neuraminidase Inhibitors Drug Market Size by Type (2018-2023) & ($ Millions)
Table 8. Global Neuraminidase Inhibitors Drug Market Size Market Share by Type (2018-2023)
Table 9. Neuraminidase Inhibitors Drug Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 10. Global Neuraminidase Inhibitors Drug Market Size by Application (2018-2023) & ($ Millions)
Table 11. Global Neuraminidase Inhibitors Drug Market Size Market Share by Application (2018-2023)
Table 12. Global Neuraminidase Inhibitors Drug Revenue by Players (2018-2023) & ($ Millions)
Table 13. Global Neuraminidase Inhibitors Drug Revenue Market Share by Player (2018-2023)
Table 14. Neuraminidase Inhibitors Drug Key Players Head office and Products Offered
Table 15. Neuraminidase Inhibitors Drug Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Neuraminidase Inhibitors Drug Market Size by Regions 2018-2023 & ($ Millions)
Table 19. Global Neuraminidase Inhibitors Drug Market Size Market Share by Regions (2018-2023)
Table 20. Global Neuraminidase Inhibitors Drug Revenue by Country/Region (2018-2023) & ($ millions)
Table 21. Global Neuraminidase Inhibitors Drug Revenue Market Share by Country/Region (2018-2023)
Table 22. Americas Neuraminidase Inhibitors Drug Market Size by Country (2018-2023) & ($ Millions)
Table 23. Americas Neuraminidase Inhibitors Drug Market Size Market Share by Country (2018-2023)
Table 24. Americas Neuraminidase Inhibitors Drug Market Size by Type (2018-2023) & ($ Millions)
Table 25. Americas Neuraminidase Inhibitors Drug Market Size Market Share by Type (2018-2023)
Table 26. Americas Neuraminidase Inhibitors Drug Market Size by Application (2018-2023) & ($ Millions)
Table 27. Americas Neuraminidase Inhibitors Drug Market Size Market Share by Application (2018-2023)
Table 28. APAC Neuraminidase Inhibitors Drug Market Size by Region (2018-2023) & ($ Millions)
Table 29. APAC Neuraminidase Inhibitors Drug Market Size Market Share by Region (2018-2023)
Table 30. APAC Neuraminidase Inhibitors Drug Market Size by Type (2018-2023) & ($ Millions)
Table 31. APAC Neuraminidase Inhibitors Drug Market Size Market Share by Type (2018-2023)
Table 32. APAC Neuraminidase Inhibitors Drug Market Size by Application (2018-2023) & ($ Millions)
Table 33. APAC Neuraminidase Inhibitors Drug Market Size Market Share by Application (2018-2023)
Table 34. Europe Neuraminidase Inhibitors Drug Market Size by Country (2018-2023) & ($ Millions)
Table 35. Europe Neuraminidase Inhibitors Drug Market Size Market Share by Country (2018-2023)
Table 36. Europe Neuraminidase Inhibitors Drug Market Size by Type (2018-2023) & ($ Millions)
Table 37. Europe Neuraminidase Inhibitors Drug Market Size Market Share by Type (2018-2023)
Table 38. Europe Neuraminidase Inhibitors Drug Market Size by Application (2018-2023) & ($ Millions)
Table 39. Europe Neuraminidase Inhibitors Drug Market Size Market Share by Application (2018-2023)
Table 40. Middle East & Africa Neuraminidase Inhibitors Drug Market Size by Region (2018-2023) & ($ Millions)
Table 41. Middle East & Africa Neuraminidase Inhibitors Drug Market Size Market Share by Region (2018-2023)
Table 42. Middle East & Africa Neuraminidase Inhibitors Drug Market Size by Type (2018-2023) & ($ Millions)
Table 43. Middle East & Africa Neuraminidase Inhibitors Drug Market Size Market Share by Type (2018-2023)
Table 44. Middle East & Africa Neuraminidase Inhibitors Drug Market Size by Application (2018-2023) & ($ Millions)
Table 45. Middle East & Africa Neuraminidase Inhibitors Drug Market Size Market Share by Application (2018-2023)
Table 46. Key Market Drivers & Growth Opportunities of Neuraminidase Inhibitors Drug
Table 47. Key Market Challenges & Risks of Neuraminidase Inhibitors Drug
Table 48. Key Industry Trends of Neuraminidase Inhibitors Drug
Table 49. Global Neuraminidase Inhibitors Drug Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 50. Global Neuraminidase Inhibitors Drug Market Size Market Share Forecast by Regions (2024-2029)
Table 51. Global Neuraminidase Inhibitors Drug Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 52. Global Neuraminidase Inhibitors Drug Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 53. Roche Details, Company Type, Neuraminidase Inhibitors Drug Area Served and Its Competitors
Table 54. Roche Neuraminidase Inhibitors Drug Product Offered
Table 55. Roche Neuraminidase Inhibitors Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 56. Roche Main Business
Table 57. Roche Latest Developments
Table 58. GSK Details, Company Type, Neuraminidase Inhibitors Drug Area Served and Its Competitors
Table 59. GSK Neuraminidase Inhibitors Drug Product Offered
Table 60. GSK Main Business
Table 61. GSK Neuraminidase Inhibitors Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 62. GSK Latest Developments
Table 63. Gilead Sciences Details, Company Type, Neuraminidase Inhibitors Drug Area Served and Its Competitors
Table 64. Gilead Sciences Neuraminidase Inhibitors Drug Product Offered
Table 65. Gilead Sciences Main Business
Table 66. Gilead Sciences Neuraminidase Inhibitors Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 67. Gilead Sciences Latest Developments
Table 68. Daiichi Sankyo Details, Company Type, Neuraminidase Inhibitors Drug Area Served and Its Competitors
Table 69. Daiichi Sankyo Neuraminidase Inhibitors Drug Product Offered
Table 70. Daiichi Sankyo Main Business
Table 71. Daiichi Sankyo Neuraminidase Inhibitors Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 72. Daiichi Sankyo Latest Developments
Table 1. Neuraminidase Inhibitors Drug Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Oseltamivir
Table 3. Major Players of Zanamivir
Table 4. Major Players of Peramivir
Table 5. Major Players of Laninamivir
Table 6. Neuraminidase Inhibitors Drug Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 7. Global Neuraminidase Inhibitors Drug Market Size by Type (2018-2023) & ($ Millions)
Table 8. Global Neuraminidase Inhibitors Drug Market Size Market Share by Type (2018-2023)
Table 9. Neuraminidase Inhibitors Drug Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 10. Global Neuraminidase Inhibitors Drug Market Size by Application (2018-2023) & ($ Millions)
Table 11. Global Neuraminidase Inhibitors Drug Market Size Market Share by Application (2018-2023)
Table 12. Global Neuraminidase Inhibitors Drug Revenue by Players (2018-2023) & ($ Millions)
Table 13. Global Neuraminidase Inhibitors Drug Revenue Market Share by Player (2018-2023)
Table 14. Neuraminidase Inhibitors Drug Key Players Head office and Products Offered
Table 15. Neuraminidase Inhibitors Drug Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Neuraminidase Inhibitors Drug Market Size by Regions 2018-2023 & ($ Millions)
Table 19. Global Neuraminidase Inhibitors Drug Market Size Market Share by Regions (2018-2023)
Table 20. Global Neuraminidase Inhibitors Drug Revenue by Country/Region (2018-2023) & ($ millions)
Table 21. Global Neuraminidase Inhibitors Drug Revenue Market Share by Country/Region (2018-2023)
Table 22. Americas Neuraminidase Inhibitors Drug Market Size by Country (2018-2023) & ($ Millions)
Table 23. Americas Neuraminidase Inhibitors Drug Market Size Market Share by Country (2018-2023)
Table 24. Americas Neuraminidase Inhibitors Drug Market Size by Type (2018-2023) & ($ Millions)
Table 25. Americas Neuraminidase Inhibitors Drug Market Size Market Share by Type (2018-2023)
Table 26. Americas Neuraminidase Inhibitors Drug Market Size by Application (2018-2023) & ($ Millions)
Table 27. Americas Neuraminidase Inhibitors Drug Market Size Market Share by Application (2018-2023)
Table 28. APAC Neuraminidase Inhibitors Drug Market Size by Region (2018-2023) & ($ Millions)
Table 29. APAC Neuraminidase Inhibitors Drug Market Size Market Share by Region (2018-2023)
Table 30. APAC Neuraminidase Inhibitors Drug Market Size by Type (2018-2023) & ($ Millions)
Table 31. APAC Neuraminidase Inhibitors Drug Market Size Market Share by Type (2018-2023)
Table 32. APAC Neuraminidase Inhibitors Drug Market Size by Application (2018-2023) & ($ Millions)
Table 33. APAC Neuraminidase Inhibitors Drug Market Size Market Share by Application (2018-2023)
Table 34. Europe Neuraminidase Inhibitors Drug Market Size by Country (2018-2023) & ($ Millions)
Table 35. Europe Neuraminidase Inhibitors Drug Market Size Market Share by Country (2018-2023)
Table 36. Europe Neuraminidase Inhibitors Drug Market Size by Type (2018-2023) & ($ Millions)
Table 37. Europe Neuraminidase Inhibitors Drug Market Size Market Share by Type (2018-2023)
Table 38. Europe Neuraminidase Inhibitors Drug Market Size by Application (2018-2023) & ($ Millions)
Table 39. Europe Neuraminidase Inhibitors Drug Market Size Market Share by Application (2018-2023)
Table 40. Middle East & Africa Neuraminidase Inhibitors Drug Market Size by Region (2018-2023) & ($ Millions)
Table 41. Middle East & Africa Neuraminidase Inhibitors Drug Market Size Market Share by Region (2018-2023)
Table 42. Middle East & Africa Neuraminidase Inhibitors Drug Market Size by Type (2018-2023) & ($ Millions)
Table 43. Middle East & Africa Neuraminidase Inhibitors Drug Market Size Market Share by Type (2018-2023)
Table 44. Middle East & Africa Neuraminidase Inhibitors Drug Market Size by Application (2018-2023) & ($ Millions)
Table 45. Middle East & Africa Neuraminidase Inhibitors Drug Market Size Market Share by Application (2018-2023)
Table 46. Key Market Drivers & Growth Opportunities of Neuraminidase Inhibitors Drug
Table 47. Key Market Challenges & Risks of Neuraminidase Inhibitors Drug
Table 48. Key Industry Trends of Neuraminidase Inhibitors Drug
Table 49. Global Neuraminidase Inhibitors Drug Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 50. Global Neuraminidase Inhibitors Drug Market Size Market Share Forecast by Regions (2024-2029)
Table 51. Global Neuraminidase Inhibitors Drug Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 52. Global Neuraminidase Inhibitors Drug Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 53. Roche Details, Company Type, Neuraminidase Inhibitors Drug Area Served and Its Competitors
Table 54. Roche Neuraminidase Inhibitors Drug Product Offered
Table 55. Roche Neuraminidase Inhibitors Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 56. Roche Main Business
Table 57. Roche Latest Developments
Table 58. GSK Details, Company Type, Neuraminidase Inhibitors Drug Area Served and Its Competitors
Table 59. GSK Neuraminidase Inhibitors Drug Product Offered
Table 60. GSK Main Business
Table 61. GSK Neuraminidase Inhibitors Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 62. GSK Latest Developments
Table 63. Gilead Sciences Details, Company Type, Neuraminidase Inhibitors Drug Area Served and Its Competitors
Table 64. Gilead Sciences Neuraminidase Inhibitors Drug Product Offered
Table 65. Gilead Sciences Main Business
Table 66. Gilead Sciences Neuraminidase Inhibitors Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 67. Gilead Sciences Latest Developments
Table 68. Daiichi Sankyo Details, Company Type, Neuraminidase Inhibitors Drug Area Served and Its Competitors
Table 69. Daiichi Sankyo Neuraminidase Inhibitors Drug Product Offered
Table 70. Daiichi Sankyo Main Business
Table 71. Daiichi Sankyo Neuraminidase Inhibitors Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 72. Daiichi Sankyo Latest Developments
LIST OF FIGURES
Figure 1. Neuraminidase Inhibitors Drug Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Neuraminidase Inhibitors Drug Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Neuraminidase Inhibitors Drug Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Neuraminidase Inhibitors Drug Sales Market Share by Country/Region (2022)
Figure 8. Neuraminidase Inhibitors Drug Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Neuraminidase Inhibitors Drug Market Size Market Share by Type in 2022
Figure 10. Neuraminidase Inhibitors Drug in Hospital Pharmacy
Figure 11. Global Neuraminidase Inhibitors Drug Market: Hospital Pharmacy (2018-2023) & ($ Millions)
Figure 12. Neuraminidase Inhibitors Drug in Retail Pharmacy
Figure 13. Global Neuraminidase Inhibitors Drug Market: Retail Pharmacy (2018-2023) & ($ Millions)
Figure 14. Neuraminidase Inhibitors Drug in Online Pharmacy
Figure 15. Global Neuraminidase Inhibitors Drug Market: Online Pharmacy (2018-2023) & ($ Millions)
Figure 16. Neuraminidase Inhibitors Drug in Others
Figure 17. Global Neuraminidase Inhibitors Drug Market: Others (2018-2023) & ($ Millions)
Figure 18. Global Neuraminidase Inhibitors Drug Market Size Market Share by Application in 2022
Figure 19. Global Neuraminidase Inhibitors Drug Revenue Market Share by Player in 2022
Figure 20. Global Neuraminidase Inhibitors Drug Market Size Market Share by Regions (2018-2023)
Figure 21. Americas Neuraminidase Inhibitors Drug Market Size 2018-2023 ($ Millions)
Figure 22. APAC Neuraminidase Inhibitors Drug Market Size 2018-2023 ($ Millions)
Figure 23. Europe Neuraminidase Inhibitors Drug Market Size 2018-2023 ($ Millions)
Figure 24. Middle East & Africa Neuraminidase Inhibitors Drug Market Size 2018-2023 ($ Millions)
Figure 25. Americas Neuraminidase Inhibitors Drug Value Market Share by Country in 2022
Figure 26. United States Neuraminidase Inhibitors Drug Market Size Growth 2018-2023 ($ Millions)
Figure 27. Canada Neuraminidase Inhibitors Drug Market Size Growth 2018-2023 ($ Millions)
Figure 28. Mexico Neuraminidase Inhibitors Drug Market Size Growth 2018-2023 ($ Millions)
Figure 29. Brazil Neuraminidase Inhibitors Drug Market Size Growth 2018-2023 ($ Millions)
Figure 30. APAC Neuraminidase Inhibitors Drug Market Size Market Share by Region in 2022
Figure 31. APAC Neuraminidase Inhibitors Drug Market Size Market Share by Type in 2022
Figure 32. APAC Neuraminidase Inhibitors Drug Market Size Market Share by Application in 2022
Figure 33. China Neuraminidase Inhibitors Drug Market Size Growth 2018-2023 ($ Millions)
Figure 34. Japan Neuraminidase Inhibitors Drug Market Size Growth 2018-2023 ($ Millions)
Figure 35. Korea Neuraminidase Inhibitors Drug Market Size Growth 2018-2023 ($ Millions)
Figure 36. Southeast Asia Neuraminidase Inhibitors Drug Market Size Growth 2018-2023 ($ Millions)
Figure 37. India Neuraminidase Inhibitors Drug Market Size Growth 2018-2023 ($ Millions)
Figure 38. Australia Neuraminidase Inhibitors Drug Market Size Growth 2018-2023 ($ Millions)
Figure 39. Europe Neuraminidase Inhibitors Drug Market Size Market Share by Country in 2022
Figure 40. Europe Neuraminidase Inhibitors Drug Market Size Market Share by Type (2018-2023)
Figure 41. Europe Neuraminidase Inhibitors Drug Market Size Market Share by Application (2018-2023)
Figure 42. Germany Neuraminidase Inhibitors Drug Market Size Growth 2018-2023 ($ Millions)
Figure 43. France Neuraminidase Inhibitors Drug Market Size Growth 2018-2023 ($ Millions)
Figure 44. UK Neuraminidase Inhibitors Drug Market Size Growth 2018-2023 ($ Millions)
Figure 45. Italy Neuraminidase Inhibitors Drug Market Size Growth 2018-2023 ($ Millions)
Figure 46. Russia Neuraminidase Inhibitors Drug Market Size Growth 2018-2023 ($ Millions)
Figure 47. Middle East & Africa Neuraminidase Inhibitors Drug Market Size Market Share by Region (2018-2023)
Figure 48. Middle East & Africa Neuraminidase Inhibitors Drug Market Size Market Share by Type (2018-2023)
Figure 49. Middle East & Africa Neuraminidase Inhibitors Drug Market Size Market Share by Application (2018-2023)
Figure 50. Egypt Neuraminidase Inhibitors Drug Market Size Growth 2018-2023 ($ Millions)
Figure 51. South Africa Neuraminidase Inhibitors Drug Market Size Growth 2018-2023 ($ Millions)
Figure 52. Israel Neuraminidase Inhibitors Drug Market Size Growth 2018-2023 ($ Millions)
Figure 53. Turkey Neuraminidase Inhibitors Drug Market Size Growth 2018-2023 ($ Millions)
Figure 54. GCC Country Neuraminidase Inhibitors Drug Market Size Growth 2018-2023 ($ Millions)
Figure 55. Americas Neuraminidase Inhibitors Drug Market Size 2024-2029 ($ Millions)
Figure 56. APAC Neuraminidase Inhibitors Drug Market Size 2024-2029 ($ Millions)
Figure 57. Europe Neuraminidase Inhibitors Drug Market Size 2024-2029 ($ Millions)
Figure 58. Middle East & Africa Neuraminidase Inhibitors Drug Market Size 2024-2029 ($ Millions)
Figure 59. United States Neuraminidase Inhibitors Drug Market Size 2024-2029 ($ Millions)
Figure 60. Canada Neuraminidase Inhibitors Drug Market Size 2024-2029 ($ Millions)
Figure 61. Mexico Neuraminidase Inhibitors Drug Market Size 2024-2029 ($ Millions)
Figure 62. Brazil Neuraminidase Inhibitors Drug Market Size 2024-2029 ($ Millions)
Figure 63. China Neuraminidase Inhibitors Drug Market Size 2024-2029 ($ Millions)
Figure 64. Japan Neuraminidase Inhibitors Drug Market Size 2024-2029 ($ Millions)
Figure 65. Korea Neuraminidase Inhibitors Drug Market Size 2024-2029 ($ Millions)
Figure 66. Southeast Asia Neuraminidase Inhibitors Drug Market Size 2024-2029 ($ Millions)
Figure 67. India Neuraminidase Inhibitors Drug Market Size 2024-2029 ($ Millions)
Figure 68. Australia Neuraminidase Inhibitors Drug Market Size 2024-2029 ($ Millions)
Figure 69. Germany Neuraminidase Inhibitors Drug Market Size 2024-2029 ($ Millions)
Figure 70. France Neuraminidase Inhibitors Drug Market Size 2024-2029 ($ Millions)
Figure 71. UK Neuraminidase Inhibitors Drug Market Size 2024-2029 ($ Millions)
Figure 72. Italy Neuraminidase Inhibitors Drug Market Size 2024-2029 ($ Millions)
Figure 73. Russia Neuraminidase Inhibitors Drug Market Size 2024-2029 ($ Millions)
Figure 74. Spain Neuraminidase Inhibitors Drug Market Size 2024-2029 ($ Millions)
Figure 75. Egypt Neuraminidase Inhibitors Drug Market Size 2024-2029 ($ Millions)
Figure 76. South Africa Neuraminidase Inhibitors Drug Market Size 2024-2029 ($ Millions)
Figure 77. Israel Neuraminidase Inhibitors Drug Market Size 2024-2029 ($ Millions)
Figure 78. Turkey Neuraminidase Inhibitors Drug Market Size 2024-2029 ($ Millions)
Figure 79. GCC Countries Neuraminidase Inhibitors Drug Market Size 2024-2029 ($ Millions)
Figure 80. Global Neuraminidase Inhibitors Drug Market Size Market Share Forecast by Type (2024-2029)
Figure 81. Global Neuraminidase Inhibitors Drug Market Size Market Share Forecast by Application (2024-2029)
Figure 1. Neuraminidase Inhibitors Drug Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Neuraminidase Inhibitors Drug Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Neuraminidase Inhibitors Drug Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Neuraminidase Inhibitors Drug Sales Market Share by Country/Region (2022)
Figure 8. Neuraminidase Inhibitors Drug Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Neuraminidase Inhibitors Drug Market Size Market Share by Type in 2022
Figure 10. Neuraminidase Inhibitors Drug in Hospital Pharmacy
Figure 11. Global Neuraminidase Inhibitors Drug Market: Hospital Pharmacy (2018-2023) & ($ Millions)
Figure 12. Neuraminidase Inhibitors Drug in Retail Pharmacy
Figure 13. Global Neuraminidase Inhibitors Drug Market: Retail Pharmacy (2018-2023) & ($ Millions)
Figure 14. Neuraminidase Inhibitors Drug in Online Pharmacy
Figure 15. Global Neuraminidase Inhibitors Drug Market: Online Pharmacy (2018-2023) & ($ Millions)
Figure 16. Neuraminidase Inhibitors Drug in Others
Figure 17. Global Neuraminidase Inhibitors Drug Market: Others (2018-2023) & ($ Millions)
Figure 18. Global Neuraminidase Inhibitors Drug Market Size Market Share by Application in 2022
Figure 19. Global Neuraminidase Inhibitors Drug Revenue Market Share by Player in 2022
Figure 20. Global Neuraminidase Inhibitors Drug Market Size Market Share by Regions (2018-2023)
Figure 21. Americas Neuraminidase Inhibitors Drug Market Size 2018-2023 ($ Millions)
Figure 22. APAC Neuraminidase Inhibitors Drug Market Size 2018-2023 ($ Millions)
Figure 23. Europe Neuraminidase Inhibitors Drug Market Size 2018-2023 ($ Millions)
Figure 24. Middle East & Africa Neuraminidase Inhibitors Drug Market Size 2018-2023 ($ Millions)
Figure 25. Americas Neuraminidase Inhibitors Drug Value Market Share by Country in 2022
Figure 26. United States Neuraminidase Inhibitors Drug Market Size Growth 2018-2023 ($ Millions)
Figure 27. Canada Neuraminidase Inhibitors Drug Market Size Growth 2018-2023 ($ Millions)
Figure 28. Mexico Neuraminidase Inhibitors Drug Market Size Growth 2018-2023 ($ Millions)
Figure 29. Brazil Neuraminidase Inhibitors Drug Market Size Growth 2018-2023 ($ Millions)
Figure 30. APAC Neuraminidase Inhibitors Drug Market Size Market Share by Region in 2022
Figure 31. APAC Neuraminidase Inhibitors Drug Market Size Market Share by Type in 2022
Figure 32. APAC Neuraminidase Inhibitors Drug Market Size Market Share by Application in 2022
Figure 33. China Neuraminidase Inhibitors Drug Market Size Growth 2018-2023 ($ Millions)
Figure 34. Japan Neuraminidase Inhibitors Drug Market Size Growth 2018-2023 ($ Millions)
Figure 35. Korea Neuraminidase Inhibitors Drug Market Size Growth 2018-2023 ($ Millions)
Figure 36. Southeast Asia Neuraminidase Inhibitors Drug Market Size Growth 2018-2023 ($ Millions)
Figure 37. India Neuraminidase Inhibitors Drug Market Size Growth 2018-2023 ($ Millions)
Figure 38. Australia Neuraminidase Inhibitors Drug Market Size Growth 2018-2023 ($ Millions)
Figure 39. Europe Neuraminidase Inhibitors Drug Market Size Market Share by Country in 2022
Figure 40. Europe Neuraminidase Inhibitors Drug Market Size Market Share by Type (2018-2023)
Figure 41. Europe Neuraminidase Inhibitors Drug Market Size Market Share by Application (2018-2023)
Figure 42. Germany Neuraminidase Inhibitors Drug Market Size Growth 2018-2023 ($ Millions)
Figure 43. France Neuraminidase Inhibitors Drug Market Size Growth 2018-2023 ($ Millions)
Figure 44. UK Neuraminidase Inhibitors Drug Market Size Growth 2018-2023 ($ Millions)
Figure 45. Italy Neuraminidase Inhibitors Drug Market Size Growth 2018-2023 ($ Millions)
Figure 46. Russia Neuraminidase Inhibitors Drug Market Size Growth 2018-2023 ($ Millions)
Figure 47. Middle East & Africa Neuraminidase Inhibitors Drug Market Size Market Share by Region (2018-2023)
Figure 48. Middle East & Africa Neuraminidase Inhibitors Drug Market Size Market Share by Type (2018-2023)
Figure 49. Middle East & Africa Neuraminidase Inhibitors Drug Market Size Market Share by Application (2018-2023)
Figure 50. Egypt Neuraminidase Inhibitors Drug Market Size Growth 2018-2023 ($ Millions)
Figure 51. South Africa Neuraminidase Inhibitors Drug Market Size Growth 2018-2023 ($ Millions)
Figure 52. Israel Neuraminidase Inhibitors Drug Market Size Growth 2018-2023 ($ Millions)
Figure 53. Turkey Neuraminidase Inhibitors Drug Market Size Growth 2018-2023 ($ Millions)
Figure 54. GCC Country Neuraminidase Inhibitors Drug Market Size Growth 2018-2023 ($ Millions)
Figure 55. Americas Neuraminidase Inhibitors Drug Market Size 2024-2029 ($ Millions)
Figure 56. APAC Neuraminidase Inhibitors Drug Market Size 2024-2029 ($ Millions)
Figure 57. Europe Neuraminidase Inhibitors Drug Market Size 2024-2029 ($ Millions)
Figure 58. Middle East & Africa Neuraminidase Inhibitors Drug Market Size 2024-2029 ($ Millions)
Figure 59. United States Neuraminidase Inhibitors Drug Market Size 2024-2029 ($ Millions)
Figure 60. Canada Neuraminidase Inhibitors Drug Market Size 2024-2029 ($ Millions)
Figure 61. Mexico Neuraminidase Inhibitors Drug Market Size 2024-2029 ($ Millions)
Figure 62. Brazil Neuraminidase Inhibitors Drug Market Size 2024-2029 ($ Millions)
Figure 63. China Neuraminidase Inhibitors Drug Market Size 2024-2029 ($ Millions)
Figure 64. Japan Neuraminidase Inhibitors Drug Market Size 2024-2029 ($ Millions)
Figure 65. Korea Neuraminidase Inhibitors Drug Market Size 2024-2029 ($ Millions)
Figure 66. Southeast Asia Neuraminidase Inhibitors Drug Market Size 2024-2029 ($ Millions)
Figure 67. India Neuraminidase Inhibitors Drug Market Size 2024-2029 ($ Millions)
Figure 68. Australia Neuraminidase Inhibitors Drug Market Size 2024-2029 ($ Millions)
Figure 69. Germany Neuraminidase Inhibitors Drug Market Size 2024-2029 ($ Millions)
Figure 70. France Neuraminidase Inhibitors Drug Market Size 2024-2029 ($ Millions)
Figure 71. UK Neuraminidase Inhibitors Drug Market Size 2024-2029 ($ Millions)
Figure 72. Italy Neuraminidase Inhibitors Drug Market Size 2024-2029 ($ Millions)
Figure 73. Russia Neuraminidase Inhibitors Drug Market Size 2024-2029 ($ Millions)
Figure 74. Spain Neuraminidase Inhibitors Drug Market Size 2024-2029 ($ Millions)
Figure 75. Egypt Neuraminidase Inhibitors Drug Market Size 2024-2029 ($ Millions)
Figure 76. South Africa Neuraminidase Inhibitors Drug Market Size 2024-2029 ($ Millions)
Figure 77. Israel Neuraminidase Inhibitors Drug Market Size 2024-2029 ($ Millions)
Figure 78. Turkey Neuraminidase Inhibitors Drug Market Size 2024-2029 ($ Millions)
Figure 79. GCC Countries Neuraminidase Inhibitors Drug Market Size 2024-2029 ($ Millions)
Figure 80. Global Neuraminidase Inhibitors Drug Market Size Market Share Forecast by Type (2024-2029)
Figure 81. Global Neuraminidase Inhibitors Drug Market Size Market Share Forecast by Application (2024-2029)
